Visible UCNPs-magnesium matrix composites for optimizing degradation and improving bone regeneration.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Nanotechnology

Background:

• Magnesium alloys are promising for bone tissue engineering due to their properties.
• Rapid degradation and lack of real-time monitoring limit magnesium alloy applications.
• Up-conversion nanoparticles (UCNPs) offer imaging capabilities and can modify material degradation.

Purpose of the Study:

• To develop and evaluate up-conversion nanoparticle/magnesium/zinc composites (UCNPs/Mg/Zn) for bone tissue engineering.
• To investigate the mechanical properties, degradation behavior, biocompatibility, and osteogenic activity of the composite.
• To assess the feasibility of using UCNPs for real-time degradation monitoring.

Main Methods:

• Powder metallurgy was used to fabricate UCNPs/Mg/Zn composites.
• Systematic evaluation of mechanical properties, in vitro and in vivo degradation, and biocompatibility.
• Assessment of osteogenic differentiation of mouse embryonic osteoblasts (MC3T3-E1).

Main Results:

• The 10% UCNPs/Mg/Zn composite (10U-Mg-4Zn) exhibited controlled degradation with a luminescence signal correlating to degradation stages.
• Compared to Mg4Zn, the 10U-Mg-4Zn composite showed a significantly reduced degradation rate.
• Improved cytocompatibility and enhanced osteogenic differentiation of MC3T3-E1 cells were observed for the 10U-Mg-4Zn composite.

Conclusions:

• The developed UCNPs/Mg/Zn composite offers a promising solution for bone tissue engineering applications.
• The composite demonstrates favorable degradation characteristics, enhanced biocompatibility, and osteogenic potential.
• The integrated UCNPs enable real-time degradation monitoring, providing a novel approach for material evaluation.